Cargando…
Corrigendum to “In silico drug repurposing against SARS-CoV-2 using an integrative transcriptomic profiling approach: Hydrocortisone and Benzhydrocodone as potential drug candidates against COVID-19” [Infection, Genetics and Evolution 103 (2022) 105318]
Autores principales: | Mirmohammadi, Seyedeh Mozhdeh, Kianmehr, Anvarsadat, Sabbaghian, Amir, Mohebbi, Alireza, Shahbazmohammadi, Hamid, Sheikharabi, Mehdi, Bazzi, Zahra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458589/ https://www.ncbi.nlm.nih.gov/pubmed/36089457 http://dx.doi.org/10.1016/j.meegid.2022.105361 |
Ejemplares similares
-
In silico drug repurposing against SARS-CoV-2 using an integrative transcriptomic profiling approach: Hydrocortisone and Benzhydrocodone as potential drug candidates against COVID-19
por: Mirmohammadi, SeyedehMozhdeh, et al.
Publicado: (2022) -
A Review of the Opioid Analgesic Benzhydrocodone-Acetaminophen
por: Mustafa, Ahmaya A, et al.
Publicado: (2018) -
Pharmacokinetics and Abuse Potential of Benzhydrocodone, a Novel Prodrug of Hydrocodone, After Intranasal Administration in Recreational Drug Users
por: Mickle, Travis C, et al.
Publicado: (2018) -
Relative Bioavailability, Intranasal Abuse Potential, and Safety of Benzhydrocodone/Acetaminophen Compared with Hydrocodone Bitartrate/Acetaminophen in Recreational Drug Abusers
por: Guenther, Sven M, et al.
Publicado: (2018) -
In silico design and analysis of a new hyperglycosylated analog of erythropoietin to improve drug efficacy
por: Kianmehr, Anvarsadat, et al.
Publicado: (2015)